CRSP had a recent pop due to the Nobel prize announcement - after a little pullback and consolidation at these levels, it looks getting poised again to reach ATHs. Long price target $115 minimum. A great fundamental and technical set up. ARKK ETF's #2 position in their portfolio. A great disruptor in the genomics sector.